Dopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation.
about
Antidepressants for smoking cessationMouse models for studying genetic influences on factors determining smoking cessation success in humans.An Association between Emotional Responsiveness and Smoking Behavior.Effects of nicotine deprivation and replacement on BOLD-fMRI response to smoking cues as a function of DRD4 VNTR genotype.Nicotine dependence as a moderator of genetic influences on smoking cessation treatment outcome.Pharmacogenetics of nicotine addiction: role of dopamineImplications of genome wide association studies for addiction: are our a priori assumptions all wrong?Pathways to precision medicine in smoking cessation treatments.Pharmacogenetic Optimization of Smoking Cessation Treatment.Biomarkers to optimize the treatment of nicotine dependence.Gender Considerations in Addiction: Implications for Treatment.Predictors of relapse in a bupropion trial for smoking cessation in recently-abstinent alcoholics: preliminary results using an aggregate genetic risk scoreThe DRD4 exon III VNTR, bupropion, and associations with prospective abstinence.Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion.A prospective study of the effects of the DRD2/ANKK1 TaqIA polymorphism and impulsivity on smoking initiation.Dopaminergic genetic variation moderates the effect of nicotine on cigarette reward.Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers.
P2860
Q24201167-A5B50546-FC47-4433-AD1E-9295EF7C8329Q30432964-D3F494DF-FF18-472A-B3E9-9D1AB6069DCEQ33560004-0233E20A-A9B1-449D-ABE8-ED9D03720D27Q33813158-36850B9E-6C7B-496B-95AE-B7EA9B14B1F5Q33893086-488DCC90-6D97-4781-BFA0-FEB928917ADEQ34132214-35DD0726-1AA6-457B-8A44-073528A8598AQ34358797-7E3387DC-98F7-4428-A490-277FB0540791Q34527740-CCD181AD-F701-441D-B1D7-EEBC8131AECCQ34542169-B80DDD5E-43C3-4008-A642-4CB5F82A63EBQ35773685-B22A6BDE-BAE6-44E3-9C47-D01D8568AF24Q36082618-067C53CD-FA0F-4896-8C84-1035AA4C9B44Q36286817-A0A3B7A2-8668-4D39-8833-5114C80E3A1EQ36929824-34646310-A44A-4923-B40C-DCF4C20E5792Q37325773-F6638EDD-1037-49AB-B7E5-0D0D241F6902Q39519836-DCEF3482-5A6A-44CB-8245-2CD30C006FCCQ40397072-2F48FF56-A668-4E2D-9A05-7D054090536DQ48015634-082BE601-13EC-4971-8BEA-E0DFB841353A
P2860
Dopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Dopamine D4 receptor gene vari ...... propion for smoking cessation.
@ast
Dopamine D4 receptor gene vari ...... propion for smoking cessation.
@en
Dopamine D4 receptor gene vari ...... propion for smoking cessation.
@nl
type
label
Dopamine D4 receptor gene vari ...... propion for smoking cessation.
@ast
Dopamine D4 receptor gene vari ...... propion for smoking cessation.
@en
Dopamine D4 receptor gene vari ...... propion for smoking cessation.
@nl
prefLabel
Dopamine D4 receptor gene vari ...... propion for smoking cessation.
@ast
Dopamine D4 receptor gene vari ...... propion for smoking cessation.
@en
Dopamine D4 receptor gene vari ...... propion for smoking cessation.
@nl
P2093
P2860
P356
P1476
Dopamine D4 receptor gene vari ...... upropion for smoking cessation
@en
P2093
A M Leventhal
E E Lloyd-Richardson
J E McGeary
M Brightman
P2860
P2888
P356
10.1038/TPJ.2010.64
P577
2010-07-27T00:00:00Z
P5875
P6179
1021602794